Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Pathology

Physiology

Internal Medicine

Pediatrics

Show all topics

DOI

10.1016/s0140-6736(18)32534-0

Other Formats

PDF